Cisatracurium Besylate
NDC 55150-286, Cisatracurium Besylate, injection, from Eugia US LLC.
- Product NDC
- 55150-286
- Status
- Listed
- Labeler
- Eugia US LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209144
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55150-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE20 mg/10mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55150-286-10 | 55150028610 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-286-10) / 10 mL in 1 VIAL, MULTI-DOSE (55150-286-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2cb05c7e-6228-4e2d-a270-7659e3db3fa7
Use it
Look up 55150-286 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55150-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55150-286. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.